“Correlation Analysis of DNA UGT1A1 Gene Expression in Hyperbilirubinemia and Central Nervous System-Related Adverse Reactions Following Oral Dolutegravir Administration”. Medinformatics 1, no. 1 (October 30, 2023): 35–42. Accessed November 24, 2024. https://ojs.bonviewpress.com/index.php/MEDIN/article/view/1466.